LIGANDAL | PRECISION GENETIC MEDICINE
  • OVERVIEW
  • COVID-19
  • OUR SCIENCE
  • NEWSROOM
  • CONTACT US

LIGANDAL

​Ligandal is a regenerative medicine and pandemic defense biotechnology company that creates ligands and delivery technologies. We've developed a machine learning approach for the rapid discovery, design and development of novel peptide therapeutics and targeting molecules for nanoscale delivery systems. 

          li·gand
             noun
           BIOCHEMISTRY
             a molecule that binds to another (usually larger) molecule.

Imagine a world where biology can be reprogrammed with the same ease as your computer. We believe in that world, and want to see the ultimate good for human health and longevity arise from these capabilities. 
     
​We use computational biology, machine learning and AI to develop next-generation medicine, bringing you nearly a decade of experience in developing peptide-based technologies for gene therapy, gene editing, regenerative medicine, immunotherapy, and advanced antidote-vaccine technologies. 
Our current lead candidate, SARS-BLOCK™, is designed as an early treatment and prophylactic against the virus that causes COVID-19. Additionally, we have numerous discovery-stage programs for the treatment of rare diseases and cancers using our platform.
LIGANDAL COVID-19 RESOURCE CENTER

SEE OUR PUBLICATION: PEPTIDE ANTIDOTES TO SARS-COV-2 (COVID-19)
Picture

"You can have the fanciest ideas and molecules, but if you can't get them into the cell, they are of no use.”

- Matthew Porteus, co-founder, crispr therapeutics

peptide-BASED nanomaterials.
targeted gene  and genome engineering delivery.
PANDEMIC DEFENSE TECHNOLOGY.
the final frontier of medicine.

delivery

We deliver antidotes, vaccines, gene therapies, gene editing, and more.

cell specificity

We can target any virtually any cellular receptor.

computational modeling

We predict how our constructs will behave, then we make them.
DISCOVER OUR PROCESS & SCIENCE

THE NEXT GENERATION OF MEDICINE IS HERE.

Ⓒ 2021 Ligandal Inc. All rights reserved.
  • OVERVIEW
  • COVID-19
  • OUR SCIENCE
  • NEWSROOM
  • CONTACT US